中恒集团 (600252)
Guangxi Wuzhou Zhongheng Group Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 319522.84
- Circulating A-Shares(W): 318416.31
- Earnings Per Share(RMB): 0.0078
- Net Assets Per Share(RMB): 1.8151
- Operating Revenue(W RMB): 194813.10
- Total Profit(W RMB): 1105.97
- **Net Profit Attributable to Parent(W RMB) **: 2464.04
- Net Profit Growth Rate(%): 119.61
- Weighted Return on Equity(%): 0.4000
- Operating Cash Flow Per Share(RMB): -0.0490
- Undistributed Profit Per Share(RMB): 0.6093
- Capital Reserve Per Share(RMB): 0.0001
2. Main Business
The main business covers:
- Pharmaceutical manufacturing
- Real estate development and operation
- Electric power
- Construction
- Hotel and tourism services
3. Company Basic Information
- Company Name: Guangxi Wuzhou Zhongheng Group Co., Ltd.
- Listing Date: 2000-11-30
- Industry: Pharmaceutical Manufacturing
- Address: No. 1 Industrial Avenue, Wuzhou Industrial Park, Guangxi Zhuang Autonomous Region
- Website: http://www.wz-zhongheng.com
- Company Profile: The company was restructured in 1993 from Wuzhou Urban Construction Comprehensive Development Company, jointly initiated by Wuzhou Real Estate Development Co., Ltd. and Wuzhou Urban Construction Design Institute, absorbing other legal entities and internal employees through a directed placement. The total share capital was 61.74925 million shares. In December 1993, it was renamed "Guangxi Wuzhou Zhongfang Co., Ltd." After a capital increase in December 1994, the total share capital became 86.74925 million shares. In 1996, after repurchasing corporate shares, the total share capital became 81.7176 million shares, and it was renamed "Guangxi Wuzhou Zhongheng Group Co., Ltd.", completing industrial and commercial registration changes in January 1997. In October 2000, it issued 45 million RMB ordinary shares via an online public offering on the Shanghai Stock Exchange. Upon successful issuance, the company became a listed company.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Guangxi Investment Group Co., Ltd. | General Legal Person | 85934.36 | 26.99 |
| 2 | Guangxi Guangtou Pharmaceutical Health Industry Group Co., Ltd. | General Legal Person | 10425.32 | 3.27 |
| 3 | Central Huijin Asset Management Co., Ltd. | Special Legal Person | 4978.08 | 1.56 |
| 4 | Southern China Securities 1000 ETF | Fund | 2423.75 | 0.76 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 2408.94 | 0.76 |
| 6 | ChinaAMC China Securities Traditional Chinese Medicine ETF | Fund | 1655.74 | 0.52 |
| 7 | ChinaAMC China Securities 1000 ETF | Fund | 1440.69 | 0.45 |
| 8 | GF China Securities 1000 ETF | Fund | 1114.05 | 0.35 |
| 9 | Xinhua Industry Leading Theme Stock Fund | Fund | 37.32 | 0.01 |
5. Concept Sectors
- Venture Capital
- Baijiu Concept
- Mask Protection
- Helicobacter Pylori
- Hepatitis Concept
- Innovative Drugs
- Margin Trading & Securities Lending
- Financial Holdings
- Low-Profit Stocks
- National Team (China Securities Finance & Central Huijin)
- Equity Transfer
- Debt-to-Asset Management Companies (AMC)
- Low-Price Stocks
- Commitment Not to Reduce Holdings
- CSI Buyback Index
- SSE 580 Index
Remarks
- Data update date: 2025-11-01
- Data source: Public Market Information
